Tuesday, November 14, 2006 6:45:00 AM PDT | VentureDeal Staff
RADNOR, PA -- Yaupon Therapeutics, a company
that develops small molecule therapies for lymphoma, addiction and neuropathic
pain, has announced a Series B funding of $4 million.
Osage Ventures of Bala Cynwyd led the round, with additional investment by
BioAdvance Greenhouse Fund, Ben Franklin Technology Partners and TDH Capital.
The company's business model is to license and advance pharmaceuticals from
under-served academic laboratories.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
Founded in 2006, VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and transactions throughout North America.
Learn More »
© 2016 VentureDeal, Inc., Menlo Park, CA. All Rights Reserved.